Category VIEW ALL
Novel Immune Based Therapeutic Strategies to Target Tumors with Alterations in LKB1 Pathway
Technology No. PAP02-04
Non-Genetic Induction of Tumor Neoantigens via Translational Errors
Technology No. BAN03-02
Targeting the Stress-Response Pathway to Promote Anti-tumor Responses
Technology No. PAP02-05
Tumor-Targeting Nanoparticles for Precision Chemotherapy in Cancer
Technology No. TRA02-06
Platform for Locally Assembling Antibody Drug Conjugates (ADCs) With Enhanced Specificity
Technology No. NEE02-08
Mutant-Selective HER2 Antibodies for Treatment of Major Cancer Types
Technology No. KOI01-08
Sindbis Virus-Based Vectors for the Oncolytic Immunotherapy of Solid Tumors
Technology No. MER02-24
S-allylcysteine for Use in the Prevention and Treatment of Plasma Cell Dyscrasias
Technology No. ORL01-32
Clinical Prognostic Models for Stage II Melanoma Using Tumor miRNA Signatures
Technology No. POL01-05
Multivalent Assembled Proteins (MAPs): Therapeutics for Cancer and Infectious Diseases
Technology No. MON02-11
Drug Targets for Overcoming Resistance to KRAS G12C Inhibitors (G12Cis) in Cancer
Technology No. NEE02-05
Anti-CD97 Antibody-Drug Conjugates for the Treatment of AML and GBM
Technology No. KOI01-16
Methods of Sensitizing Estrogen Receptor-Positive Breast Cancer to Endocrine Therapy
Technology No. SCH03-09
Treatment of Melanoma Brain Metastasis by Inhibition of Amyloid Precursor Protein Cleavage
Technology No. HER02-07
Method of Treating Lung Cancer in Patients with LKB1 Genetically-Inactivated Tumors
Technology No. WON02-07
iScore: A Novel Method for Improved Risk Stratification of AML Patients
Technology No. AIF01-12
Novel Targets for Cancer Therapy
Technology No. WON02-04
Therapeutic Targeting of KMT2D Mutant Lung Cancer Via RTK-RAS Signaling Inhibition
Technology No. WON02-05
Targeting a Novel Metabolic Network for Pancreatic Ductal Adenocarcinoma (PDAC) Treatment
Technology No. KIM06-01
Multivalent Steroid Conjugates for Treatment of Castration-Resistant Prostate Cancer (CRPC)
Technology No. KIR01-10
Anti-CD99 Antibodies Cytotoxic to Leukemia
Technology No. KOI01-05
TET2 Modulators for the Treatment of Cancer and Inflammatory Diseases
Technology No. AIF01-09
A Novel Blood Marker for Prognostication and Treatment of Non-Small Cell Lung Cancer
Technology No. PAS02-13
